Cargando…
Hydroxychloroquine-Induced Myopathy Responding to Intravenous Immunoglobulin (IVIG)
Hydroxychloroquine (HCQ), a drug used to treat many diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), has limited reports documenting drug-induced myopathies as a side effect. This entity is underdiagnosed with unclear treatment interventions apart from discontinuing...
Autores principales: | Almoallim, Hani, Samkari, Alaa, Fallata, Ahmad, Adam, Heba, Kary, Malak, Bahabri, Mohammed, Cheikh, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372520/ https://www.ncbi.nlm.nih.gov/pubmed/37519556 http://dx.doi.org/10.7759/cureus.41016 |
Ejemplares similares
-
Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis
por: AlQadri, Nada G, et al.
Publicado: (2020) -
A Case of Statin-Associated Immune-Mediated Necrotizing Myopathy, Successfully Treated With Intravenous Immunoglobulin
por: Paul, Mishouri, et al.
Publicado: (2021) -
Evaluating the Use of Hydroxychloroquine in Treating Patients With Rheumatoid Arthritis
por: Nazir, Armaan M, et al.
Publicado: (2021) -
Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations
por: Hooper, John A.
Publicado: (2008) -
OptimisAtion of Diagnostic Accuracy in idioPathic inflammaTory myopathies (ADAPT study): a protocol for a prospective diagnostic accuracy study of multimodality testing in patients suspected of a treatable idiopathic inflammatory myopathy
por: Walter, Hannah A W, et al.
Publicado: (2021)